The World Health Organization has called for a radical rethinking of global drug policies as new data reveals substance abuse now drains up to 2% of GDP from affected nations through healthcare costs and lost productivity.
The appeal comes on International Day Against Drug Abuse and Illicit Trafficking, with WHO highlighting how punitive approaches have failed to curb a crisis affecting 292 million people worldwide.
In the Eastern Mediterranean Region, where 6.7% of adults use drugs, fewer than 8% of those with substance disorders receive treatment despite evidence showing each dollar invested in care yields $4-12 in social returns. The disparity prompted WHO’s October 2024 launch of a regional initiative promoting school-based prevention programs and harm reduction strategies over criminalization. “We cannot arrest our way out of a public health crisis,” said Dr. Ahmed Al-Mandhari, WHO Regional Director, noting the approach has exacerbated stigma while allowing cardiovascular diseases and tuberculosis to flourish among untreated users.
The economic argument for reform grows increasingly urgent as governments face strained budgets. Beyond direct healthcare costs, substance abuse destabilizes communities and fuels crime – a reality Ghana confronts as opioid use surges in urban centers. The WHO plan emphasizes integrating treatment into universal health coverage, a model piloted in Lebanon where community clinics saw relapse rates drop 40% after implementing medication-assisted therapy.
With the initiative now forming regional advisory groups including recovered users, WHO aims to scale such successes. As the deadline looms for UN Sustainable Development Goals, health experts warn current drug policies jeopardize targets on poverty reduction and social stability. The agency’s calculus is clear: the higher cost lies in maintaining the status quo.
